Deerfield Management’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-166,162
| Closed | -$3.23M | – | 152 |
|
|
2024
Q4 | $3.23M | Hold |
166,162
| – | – | 0.06% | 74 |
|
|
2024
Q3 | $2.6M | Hold |
166,162
| – | – | 0.04% | 77 |
|
|
2024
Q2 | $1.4M | Hold |
166,162
| – | – | 0.02% | 97 |
|
|
2024
Q1 | $2.56M | Hold |
166,162
| – | – | 0.04% | 78 |
|
|
2023
Q4 | $2.29M | Hold |
166,162
| – | – | 0.04% | 62 |
|
|
2023
Q3 | $1.9M | Sell |
166,162
-48,867
| -23% | -$908K | 0.04% | 73 |
|
|
2023
Q2 | $5.35M | Hold |
215,029
| – | – | 0.11% | 79 |
|
|
2023
Q1 | $7.81M | Hold |
215,029
| – | – | 0.17% | 76 |
|
|
2022
Q4 | $13M | Sell |
215,029
-20,905
| -9% | -$1.4M | 0.27% | 68 |
|
|
2022
Q3 | $17.7M | Buy |
235,934
+24,723
| +12% | +$2.58M | 0.35% | 67 |
|
|
2022
Q2 | $24.2M | Sell |
211,211
-9,190
| -4% | -$1.08M | 0.5% | 54 |
|
|
2022
Q1 | $41.7M | Sell |
220,401
-83,333
| -27% | -$19.3M | 0.93% | 35 |
|
|
2021
Q4 | $105M | Hold |
303,734
| – | – | 2.21% | 11 |
|
|
2021
Q3 | $102M | Hold |
303,734
| – | – | 1.99% | 14 |
|
|
2021
Q2 | $250M | Buy |
+303,734
| New | +$235M | 4.45% | 2 |
|
Deerfield Management's OMIC Position: Q1 2025 in Review
Deerfield Management sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q1 2025, closing a stake of 166,162 shares — an estimated $3.23M sold.
Deerfield Management first reported a position in OMIC in Q2 2021 and held it in 15 quarters. The position peaked at $250M in Q2 2021. 0 funds tracked by Wall St. Rank hold OMIC as of Q1 2025.
- Deerfield Management reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
- Deerfield Management sold 166,162 Singular Genomics Systems, Inc. Common Stock shares in Q1 2025, an estimated $3.23M.
- Deerfield Management first reported a position in Singular Genomics Systems, Inc. Common Stock in Q2 2021 and held it in 15 quarters.
- Deerfield Management's Singular Genomics Systems, Inc. Common Stock position peaked at $250M in Q2 2021.
- 0 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q1 2025.
Based on Deerfield Management's 13F filing for Q1 2025, filed 15 May 2025.